Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2594

1.

Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?

Stillemans G, Belkhir L, Hesselink DA, Haufroid V, Elens L.

Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):601-611. doi: 10.1080/17425255.2018.1478964. Epub 2018 May 28. Review.

PMID:
29775551
2.

Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.

Wu C, Li W.

Crit Rev Oncol Hematol. 2018 Jun;126:100-111. doi: 10.1016/j.critrevonc.2018.04.002. Epub 2018 Apr 10. Review.

PMID:
29759551
3.

Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.

Del Re M, Crucitta S, Restante G, Rofi E, Arrigoni E, Biasco E, Sbrana A, Coppi E, Galli L, Bracarda S, Santini D, Danesi R.

Crit Rev Oncol Hematol. 2018 May;125:51-59. doi: 10.1016/j.critrevonc.2018.03.002. Epub 2018 Mar 6. Review.

PMID:
29650277
4.

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.

El Rouby N, Lima JJ, Johnson JA.

Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):447-460. doi: 10.1080/17425255.2018.1461835. Epub 2018 Apr 12. Review.

5.

Pharmacogenetics and application in pediatrics.

Neyro V, Jacqz-Aigrain E, Adam de Beaumais T.

Therapie. 2018 Apr;73(2):157-163. doi: 10.1016/j.therap.2017.11.010. Epub 2018 Feb 16. Review.

PMID:
29530313
6.

How does race/ethnicity influence pharmacological response to asthma therapies?

Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani P.

Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):435-446. doi: 10.1080/17425255.2018.1449833. Epub 2018 Mar 12. Review.

PMID:
29528249
7.

[Drug-Drug Interactions with Consideration of Pharmacogenetics].

Ozawa S.

Yakugaku Zasshi. 2018;138(3):365-371. doi: 10.1248/yakushi.17-00191-5. Review. Japanese.

8.

[MODERN VIEWS ON THE PHARMACOGENETICS OF PAIN.]

Makharin OA, Zhenilo VM, Patyuchenko OY.

Anesteziol Reanimatol. 2017 Sep;61:219-223. Review. Russian.

PMID:
29465208
9.

Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?

Motta I, Calcagno A, Bonora S.

Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):59-82. doi: 10.1080/17425255.2018.1416093. Epub 2017 Dec 18. Review.

PMID:
29226732
10.

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.

Lauschke VM, Milani L, Ingelman-Sundberg M.

AAPS J. 2017 Nov 27;20(1):4. doi: 10.1208/s12248-017-0161-x. Review.

PMID:
29181807
11.

Treatment response heterogeneity in asthma: the role of genetic variation.

Vijverberg SJH, Farzan N, Slob EMA, Neerincx AH, Maitland-van der Zee AH.

Expert Rev Respir Med. 2018 Jan;12(1):55-65. doi: 10.1080/17476348.2018.1403318. Epub 2017 Nov 21. Review.

PMID:
29115880
12.

Pharmacogenomics: Precision Medicine and Drug Response.

Weinshilboum RM, Wang L.

Mayo Clin Proc. 2017 Nov;92(11):1711-1722. doi: 10.1016/j.mayocp.2017.09.001. Epub 2017 Nov 1. Review.

PMID:
29101939
13.

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.

Martin A, Downing J, Maden M, Fleeman N, Alfirevic A, Haycox A, Pirmohamed M.

Pharmacogenomics. 2017 Nov;18(16):1541-1550. doi: 10.2217/pgs-2017-0076. Epub 2017 Nov 2. Review.

PMID:
29095091
14.

Pharmacogenomics in acute lymphoblastic leukemia.

Lee SHR, Yang JJ.

Best Pract Res Clin Haematol. 2017 Sep;30(3):229-236. doi: 10.1016/j.beha.2017.07.007. Epub 2017 Jul 27. Review.

PMID:
29050696
15.

Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.

Amsden JR, Gubbins PO.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1135-1146. doi: 10.1080/17425255.2017.1391213. Epub 2017 Oct 20. Review.

PMID:
29022838
16.

Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.

Neary M, Owen A.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1169-1181. doi: 10.1080/17425255.2017.1391214. Epub 2017 Oct 16. Review.

PMID:
28994310
17.

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.

Matera MG, Rinaldi B, Calzetta L, Cazzola M.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1159-1167. doi: 10.1080/17425255.2017.1391215. Epub 2017 Oct 23. Review.

PMID:
28992739
18.

Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.

Scott SA, Owusu Obeng A, Botton MR, Yang Y, Scott ER, Ellis SB, Wallsten R, Kaszemacher T, Zhou X, Chen R, Nicoletti P, Naik H, Kenny EE, Vega A, Waite E, Diaz GA, Dudley J, Halperin JL, Edelmann L, Kasarskis A, Hulot JS, Peter I, Bottinger EP, Hirschhorn K, Sklar P, Cho JH, Desnick RJ, Schadt EE.

Pharmacogenomics. 2017 Oct;18(15):1381-1386. doi: 10.2217/pgs-2017-0137. Epub 2017 Oct 6. Review.

PMID:
28982267
19.

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Jones AR, Sproviero W, Shatunov A, Shaw PJ, Leigh PN, Young CA, Shaw CE, Mora G, Mandrioli J, Borghero G, Volanti P, Diekstra FP, van Rheenen W, Verstraete E, Eijkemans MJC, Veldink JH, Chio A, Al-Chalabi A, van den Berg LH, van Es MA; For UKMND-LiCALS and LITALS Study Group.

Neurology. 2017 Oct 31;89(18):1915-1922. doi: 10.1212/WNL.0000000000004606. Epub 2017 Oct 4. Review. Erratum in: Neurology. 2017 Nov 28;89(22):2303.

20.

Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.

Parikh KS, Piccini JP.

Curr Heart Fail Rep. 2017 Dec;14(6):529-535. doi: 10.1007/s11897-017-0364-6. Review.

PMID:
28975475

Supplemental Content

Loading ...
Support Center